Author Index

Search or browse for an author across our entire electronic archive

Search results for: K
Results 101 - 110 of 1817 shown below

  • Kakizaki, M

    M Kakizaki, K Inoue, S Kuriyama, T Sone, K Matsuda-Ohmori, N Nakaya, S Fukudo and I Tsuji

    Sleep duration and the risk of prostate cancer: the Ohsaki Cohort Study

    advance online publication, 2008-06-10 00:00:00.000;

    doi:10.1038/sj.bjc.6604425

  • Q Li, M Kakizaki, S Kuriyama, T Sone, H Yan, N Nakaya, K Mastuda-Ohmori and I Tsuji

    Green tea consumption and lung cancer risk: the Ohsaki study

    advance online publication, 2008-09-02 00:00:00.000;

    doi:10.1038/sj.bjc.6604645

  • M Kakizaki, S Kuriyama, T Sone, K Ohmori-Matsuda, A Hozawa, N Nakaya, S Fukudo and I Tsuji

    Sleep duration and the risk of breast cancer: the Ohsaki Cohort Study

    advance online publication, 2008-09-23 00:00:00.000;

    doi:10.1038/sj.bjc.6604684

  • Y Sugawara, S Kuriyama, M Kakizaki, M Nagai, K Ohmori-Matsuda, T Sone, A Hozawa, Y Nishino and I Tsuji

    Fish consumption and the risk of colorectal cancer: the Ohsaki Cohort Study

    advance online publication, 2009-07-28 00:00:00.000;

    doi:10.1038/sj.bjc.6605217

  • Kakizoe, T

    T Hamaguchi, Y Matsumura, M Suzuki, K Shimizu, R Goda, I Nakamura, I Nakatomi, M Yokoyama, K Kataoka and T Kakizoe

    NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel

    advance online publication, 2005-03-22 00:00:00.000;

    doi:10.1038/sj.bjc.6602479

  • H Uchino, Y Matsumura, T Negishi, F Koizumi, T Hayashi, T Honda, N Nishiyama, K Kataoka, S Naito and T Kakizoe

    Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

    advance online publication, 2005-09-13 00:00:00.000;

    doi:10.1038/sj.bjc.6602772

  • Kakkar, A J

    P H Jones, K Christodoulos, N Dobbs, P Thavasu, F Balkwill, A D Blann, G J Caine, S Kumar, A J Kakkar, N Gompertz, D C Talbot, T S Ganesan and A L Harris

    Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

    advance online publication, 2004-05-25 00:00:00.000;

    doi:10.1038/sj.bjc.6601897

  • A O'Donnell, A Padhani, C Hayes, A J Kakkar, M Leach, J M Trigo, M Scurr, F Raynaud, S Phillips, W Aherne, A Hardcastle, P Workman, A Hannah and I Judson

    A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points

    doi:10.1038/sj.bjc.6602797

  • Kaklamanis, L

    K Smith, T D Bui, R Poulsom, L Kaklamanis, G Williams and A L Harris

    Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer

    doi:10.1038/sj.bjc.6690721

  • Kakolyris, S

    J Souglakos, N Androulakis, K Syrigos, A Polyzos, N Ziras, A Athanasiadis, S Kakolyris, S Tsousis, Ch Kouroussis, L Vamvakas, A Kalykaki, G Samonis, D Mavroudis and V Georgoulias

    FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic

    advance online publication, 2006-02-28 00:00:00.000;

    doi:10.1038/sj.bjc.6603011

  • S Kakolyris, S B Fox, M Koukourakis, A Giatromanolaki, N Brown, R D Leek, M Taylor, I M Leigh, K C Gatter and A L Harris

    Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39

    doi:10.1054/bjoc.1999.1010

  • K Kalbakis, Ch Kouroussis, S Kakolyris, D Mavroudis, J Souglakos, S Agelaki, L Vamvakas, M Christodoulakis, K Stylianou and V Georgoulias

    Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracyclin

    doi:10.1054/bjoc.2001.2001

  • Kaku, T

    K Sonoda, S Miyamoto, T Hirakawa, T Kaku, M Nakashima, T Watanabe, K Akazawa, T Fujita and H Nakano

    Association between RCAS1 expression and clinical outcome in uterine endometrial cancer

    doi:10.1038/sj.bjc.6601126

  • Kakudo, K

    Y Ito, H Yoshida, K Nakano, K Kobayashi, T Yokozawa, K Hirai, F Matsuzuka, N Matsuura, K Kakudo, K Kuma and A Miyauchi

    Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid

    doi:10.1038/sj.bjc.6600172

  • Y Ito, H Yoshida, K Nakano, K Kobayashi, T Yokozawa, K Hirai, F Matsuzuka, N Matsuura, K Kakudo, K Kuma and A Miyauchi

    Expression of cdc25A and cdc25B proteins in thyroid neoplasms

    doi:10.1038/sj.bjc.6600364

  • Y Ito, E Miyoshi, N Sasaki, K Kakudo, H Yoshida, C Tomoda, T Uruno, Y Takamura, A Miya, K Kobayashi, F Matsuzuka, N Matsuura, K Kuma and A Miyauchi

    Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma

    doi:10.1038/sj.bjc.6601540

  • Kakudo, Y

    T Yoshioka, S Kato, M Gamoh, N Chiba, T Suzuki, N Sakayori, S Kato, H Shibata, H Shimodaira, K Otsuka, Y Kakudo, S Takahashi and C Ishioka

    Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer

    advance online publication, 2009-11-17 00:00:00.000;

    doi:10.1038/sj.bjc.6605432

  • Kakugawa, Y

    H Shoda, Y Kakugawa, D Saito, T Kozu, T Terauchi, H Daisaki, C Hamashima, Y Muramatsu, N Moriyama and H Saito

    Evaluation of 18F-2-deoxy-2-fluoro-glucose positron emission tomography for gastric cancer screening in asymptomatic individuals undergoing endoscopy

    advance online publication, 2007-11-27 00:00:00.000;

    doi:10.1038/sj.bjc.6604062

  • Kakuguchi, W

    H Hasegawa, W Kakuguchi, T Kuroshima, T Kitamura, S Tanaka, Y Kitagawa, Y Totsuka, M Shindoh and F Higashino

    HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells

    doi:10.1038/sj.bjc.6605084